157 related articles for article (PubMed ID: 31269290)
21. miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.
Li N; Zhao X; Wang L; Zhang S; Cui M; He J
Tumour Biol; 2016 Jun; 37(6):7767-76. PubMed ID: 26695144
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.
Mudduluru G; Ceppi P; Kumarswamy R; Scagliotti GV; Papotti M; Allgayer H
Oncogene; 2011 Jun; 30(25):2888-99. PubMed ID: 21317930
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.
El Bezawy R; De Cesare M; Pennati M; Deraco M; Gandellini P; Zuco V; Zaffaroni N
J Hematol Oncol; 2017 Jan; 10(1):19. PubMed ID: 28100259
[TBL] [Abstract][Full Text] [Related]
24. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer.
Beveridge DJ; Richardson KL; Epis MR; Brown RAM; Stuart LM; Woo AJ; Leedman PJ
Sci Rep; 2021 Sep; 11(1):18003. PubMed ID: 34504167
[TBL] [Abstract][Full Text] [Related]
25. The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.
Paccez JD; Vasques GJ; Correa RG; Vasconcellos JF; Duncan K; Gu X; Bhasin M; Libermann TA; Zerbini LF
Oncogene; 2013 Feb; 32(6):689-98. PubMed ID: 22410775
[TBL] [Abstract][Full Text] [Related]
26. MiR-99a suppresses cell migration and invasion by regulating IGF1R in gastric cancer.
Xu XL; Guo AX; Pan QY; Chang AL; Zhao CR
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7375-7382. PubMed ID: 31539124
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus miR-BART4-3p regulates cell proliferation, apoptosis, and migration by targeting AXL in gastric carcinoma.
Zhao MH; Liu W; Zhang Y; Liu JJ; Song H; Luo B
Virus Genes; 2022 Feb; 58(1):23-34. PubMed ID: 35083633
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF‑1R.
Liao G; Chen F; Zhong J; Jiang X
Mol Med Rep; 2018 Apr; 17(4):4917-4924. PubMed ID: 29393438
[TBL] [Abstract][Full Text] [Related]
29. [MiR-126 inhibits the proliferation and invasion of gastric cancer by downregulation of IGF-1R].
Wang H; Wang G; Tian WL
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):508-515. PubMed ID: 31357837
[No Abstract] [Full Text] [Related]
30. MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways.
Zhou F; Nie L; Feng D; Guo S; Luo R
Oncol Rep; 2017 Sep; 38(3):1857-1866. PubMed ID: 28731178
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases.
Arora S; Saini S; Fukuhara S; Majid S; Shahryari V; Yamamura S; Chiyomaru T; Deng G; Tanaka Y; Dahiya R
PLoS One; 2013; 8(11):e78023. PubMed ID: 24223753
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor.
Liu YC; Park YR; Kim SL; Lee ST; Kim SW
Dig Dis Sci; 2017 Nov; 62(11):3040-3049. PubMed ID: 28932920
[TBL] [Abstract][Full Text] [Related]
33. MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.
Wang B; Wang H; Yang Z
PLoS One; 2012; 7(10):e47053. PubMed ID: 23056576
[TBL] [Abstract][Full Text] [Related]
34. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
Guo K; Zheng S; Xu Y; Xu A; Chen B; Wen Y
Tumour Biol; 2016 Sep; 37(9):12843-12854. PubMed ID: 27449037
[TBL] [Abstract][Full Text] [Related]
35. MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.
Zheng L; Kang Y; Zhang L; Zou W
Cancer Biol Ther; 2020; 21(1):34-42. PubMed ID: 31736422
[TBL] [Abstract][Full Text] [Related]
36. An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets
Hajalirezay Yazdi S; Paryan M; Mohammadi-Yeganeh S
Cell Mol Biol Lett; 2018; 23():51. PubMed ID: 30386383
[TBL] [Abstract][Full Text] [Related]
37. Axl receptor tyrosine kinase is a novel target of apigenin for the inhibition of cell proliferation.
Kim KC; Choi EH; Lee C
Int J Mol Med; 2014 Aug; 34(2):592-8. PubMed ID: 24926787
[TBL] [Abstract][Full Text] [Related]
38. lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition.
Jiang N; Wang X; Xie X; Liao Y; Liu N; Liu J; Miao N; Shen J; Peng T
Cancer Lett; 2017 Oct; 405():46-55. PubMed ID: 28642170
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
Sun W; Zu S; Shao G; Wang W; Gong F
J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]